On this page
Tazdin Esmail
Insider
First SEC filing: May 16, 2005 · Latest: May 16, 2005
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2008 | INO | A | 15,000 | $0.89 | $13,350 | 15,000 Direct | · | Acquired | -97.3% (price as of 2026-10-05) |
| May 4, 2007 | INO | A | 15,000 | $3.75 | $56,250 | 15,000 Direct | · | Acquired | -99.4% (price as of 2026-10-05) |
| June 7, 2006 | INO | A | 25,000 | $2.23 | $55,750 | 25,000 Direct | · | Acquired | -98.9% (price as of 2026-10-05) |
| May 13, 2005 | INO | A | 10,000 | $3.34 | $33,400 | 10,000 Direct | · | Acquired | -99.3% (price as of 2026-10-05) |
| Sept. 16, 2004 | INO | P | 1,029 | $8.80 | $9,055 | 1,029 Direct | · | Acquired | -99.7% (price as of 2026-10-05) |
| Sept. 16, 2004 | INO | P | 2 | $11764.71 | $23,529 | 2 Direct | · | Acquired | -100.0% (price as of 2026-10-05) |
| Aug. 6, 2004 | INO | A | 20,000 | $0.93 | $18,600 | 20,000 Direct | · | Acquired | -99.4% (price as of 2026-10-05) |
| June 17, 2004 | INO | A | 35,000 | $1.33 | $46,550 | 35,000 Direct | · | Acquired | -99.5% (price as of 2026-10-05) |
| Aug. 8, 2003 | INO | A | 85,000 | $0.63 | $53,550 | 250,000 Direct | +51.52% | Acquired | -99.0% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 2, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock Option | $0.89 | May 2, 2018 | 15,000 | Acquired |
| May 4, 2007 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock | $3.75 | May 4, 2017 | 15,000 | Acquired |
| June 7, 2006 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock | $2.23 | June 7, 2016 | 25,000 | Acquired |
| May 13, 2005 | INO | Inovio Biomedical Corporation Common Stock | Inovio Biomedical Corporation Common Stock | $3.34 | May 12, 2015 | 10,000 | Acquired |
| Sept. 16, 2004 | INO | Genetronics Biomedical Corporation Common Stock Warrants | Genetronics Biomedical Corporation Common Stock Warrants | $8.80 | May 10, 2004 | 1,029 | Acquired |
| Aug. 6, 2004 | INO | Common Stock | Common Stock | $0.93 | Aug. 5, 2014 | 20,000 | Acquired |
| June 17, 2004 | INO | Common Stock | Common Stock | $1.33 | June 16, 2014 | 35,000 | Acquired |
| Aug. 8, 2003 | INO | Common Stock | Common Stock | $0.63 | Aug. 7, 2013 | 85,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).